IP Library Granted Patent US 10,081,807
Granted Patent B2
US 10,081,807 · App. 13/986,366 · Granted Sep 25, 2018

Methods for sorting nucleic acids and multiplexed preparative in vitro cloning

Inventors: Joseph Jacobson (Newton, MA); Martin J. Goldberg (Saratoga, CA); Li-yun A. Kung (Arlington, MA); Daniel Schindler (Newton, MA); Michael E. Hudson (Framingham, MA)
Assignee: Gen9, Inc.
C12N15/1065C12N15/1034C12N15/1093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,807
App. No.
13/986,366
Granted
Sep 25, 2018
Kind
B2
Abstract

Methods and compositions relate to the sorting and cloning of high fidelity nucleic acids using high throughput sequencing. Specifically, nucleic acid molecules having the desired predetermined sequence can be sorted from a pool comprising a plurality of nucleic acids having correct and incorrect sequences.

Claims (17)

1. A method of sorting nucleic acid molecules having a predetermined sequence, the method comprising:

(a) providing a pool of nucleic acid molecules comprising at least two populations of nucleic acid molecules, each population having (i) a unique target nucleic acid sequence that is the same for each population, the target nucleic acid sequence having two ends, and (ii) a pair of non-target oligonucleotide tag sequences at the two ends of each target nucleic acid sequence, such that in the pool of nucleic acid molecules, each oligonucleotide tag sequence comprises a unique portion for each target nucleic acid sequence; wherein the pool was prepared by tagging target nucleic acid molecules with a library of non-target oligonucleotide tag sequences that are present in a greater number than the target nucleic acid molecules;

(b) sequencing the nucleic acid molecules from both ends to obtain a paired end read; and

(c) sorting nucleic acid molecules having a predetermined sequence according to the identity of their corresponding paired end read.

2. The method of claim 1 further comprising amplifying the nucleic acid molecules having the predetermined sequence.

3. The method of claim 2 further comprising amplifying the nucleic acid molecules having the predetermined sequence using primers complementary to at least part of the oligonucleotide tag sequence.

4. The method of claim 1 wherein the target nucleic acid molecules comprises a first population of target nucleic acid molecules having the predetermined sequence and a second population of target nucleic acid molecules having a sequence different than the predetermined sequence.

5. The method of claim 4 further comprising assembling a plurality of target nucleic acid molecules onto a solid support and pooling the target nucleic acid molecules.

6. The method of claim 5 further comprising diluting the target nucleic acid molecules.

7. The method of claim 1 further comprising diluting the pool of nucleic acid molecules.

8. The method of claim 1 wherein the non-target oligonucleotide tag sequences are ligated to the two ends of each of the target nucleic acid molecules.

9. The method of claim 8 wherein the non-target oligonucleotide tag sequences are added to the target nucleic acid molecules by ligating the target nucleic acid molecules with one or more nucleic acid molecules comprising the non-target oligonucleotide tag sequences.

10. The method of claim 9 wherein the one or more nucleic acid molecules comprising the non-target oligonucleotide tag sequences are vectors.

11. The method of claim 1 wherein in the step of providing, the non-target oligonucleotide tag sequences are joined to the two ends of each of the target nucleic acid molecules by polymerase chain reaction.

12. The method of claim 1 wherein each non-target oligonucleotide tag sequence includes a degenerate nucleotide sequence, or a partially degenerate sequence.

13. The method of claim 12 wherein the degenerate nucleotide sequence is CCWSWDHSHDBVHDNNNNMM and/or CCSWSWHDSDHVBDHNNNNMM, wherein W represents A or T, S represents G or C, M represents A or C, B represents C, G or T, D represents A, G or T, H represents A, C or T, V represents A, C, or G and N represents any base A, C, G or T.

14. The method of claim 2 wherein in the step of amplifying the primers are complementary to the pair of non-target oligonucleotide tag sequences.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: GINKGO BIOWORKS, INC.
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 072092/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: GEN9, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 071945/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2015
From: JACOBSON, JOSEPH; GOLDBERG, MARTIN J.; KUNG, LI-YUN A.; SCHINDLER, DANIEL; HUDSON, MICHAEL E.
To: GEN9, INC.
Reel/Frame 037047/0784 →
Continuity (5)
Provisional Application 61851774 · Mar 13, 2013
Provisional Application 61848961 · Jan 16, 2013
Provisional Application 61637750 · Apr 24, 2012
Provisional Application 61638187 · Apr 25, 2012
Related Publication 20140141982A1 · May 22, 2014
Cited By (2)
US 12,319,910 US 12,630,819